Search

Your search keyword '"Aigner, Elmar"' showing total 549 results

Search Constraints

Start Over You searched for: Author "Aigner, Elmar" Remove constraint Author: "Aigner, Elmar"
549 results on '"Aigner, Elmar"'

Search Results

5. Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial

8. Austrian consensus on the diagnosis and management of portal hypertension in advanced chronic liver disease (Billroth IV)

9. Author Correction: Consensus Statement on the definition and classification of metabolic hyperferritinaemia

10. Alpha-1 Antitrypsin Augmentation and the Liver Phenotype of Adults With Alpha-1 Antitrypsin Deficiency (Genotype Pi∗ZZ)

11. Consensus Statement on the definition and classification of metabolic hyperferritinaemia

14. Outcome of Budd-Chiari Syndrome Patients Treated With Direct Oral Anticoagulants: An Austrian Multicenter Study

16. FRI-009-YI Diagnostic and prognostic performance of the LiverRisk score in tertiary care

17. FRI-303 Depression as a determinant of metabolic dysfunction-associated steatotic liver disease (MASLD) risk in the Paracelsus 10, 000 study

18. FRI-394 High burden of cirrhosis and increasing response rates to bulevirtide-based regimens: insights from the austrian prospective hepatitis D registry

20. Association between Diverticulosis and Colorectal Neoplasia: Analysis from a Large Austrian Database.

21. Simple blood tests to diagnose compensated advanced chronic liver disease and stratify the risk of clinically significant portal hypertension.

23. PSD3 downregulation confers protection against fatty liver disease

26. Combined effects of PNPLA3, TM6SF2 and HSD17B13 variants on severity of biopsy-proven non-alcoholic fatty liver disease

28. Investigating the Added Value of Beck's Depression Inventory in Atherosclerosis Prediction: Lessons from Paracelsus 10,000.

29. Association between Cardiovascular Risk Assessment by SCORE2 and Diverticulosis: A Cross-Sectional Analysis.

32. Screening program in healthy individuals reveals a high prevalence of chronic hepatitis C in the general population of Austria

33. Prevalence and Characteristics of Metabolic Hyperferritinemia in a Population-Based Central-European Cohort

34. Author Correction: Consensus Statement on the definition and classification of metabolic hyperferritinaemia

36. Norursodeoxycholic acid versus placebo in the treatment of non-alcoholic fatty liver disease: a double-blind, randomised, placebo-controlled, phase 2 dose-finding trial

37. Liver Fibrosis and Metabolic Alterations in Adults With alpha-1-antitrypsin Deficiency Caused by the Pi*ZZ Mutation

38. Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial

39. The Impact of Educational Status on the Occurrence of Colonic Diverticula: Insights from an Austrian Cohort Study.

41. Prevalence of Subclinical Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease: Analysis of the Paracelsus 10,000 Cohort Study

42. Alpha-1 antitrypsin (AAT) augmentation and the liver phenotype of adults with AAT deficiency (genotype Pi*ZZ)

45. Relationships between education and non-alcoholic fatty liver disease

47. Metabolomic profiling identifies potential pathways involved in the interaction of iron homeostasis with glucose metabolism

48. Gender-Specific Bile Acid Profiles in Non-Alcoholic Fatty Liver Disease.

50. Genetic Variants Determine Treatment Response in Autoimmune Hepatitis

Catalog

Books, media, physical & digital resources